Can Waves of Autoimmune Diseases Occur after The COVID-19 Pandemic?
Infect Disord Drug Targets. 2023 Dec 19. doi: 10.2174/0118715265272448231211101718. Online ahead of print.NO ABSTRACTPMID:38115613 | DOI:10.2174/0118715265272448231211101718 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - December 20, 2023 Category: Infectious Diseases Authors: SeyedAhmad SeyedAlinaghi Pegah Mirzapour Esmaeil Mehraeen Source Type: research
An Unforeseen Spreading of Measles in South Africa
Infect Disord Drug Targets. 2023 Dec 19. doi: 10.2174/0118715265276129231211054120. Online ahead of print.NO ABSTRACTPMID:38115612 | DOI:10.2174/0118715265276129231211054120 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - December 20, 2023 Category: Infectious Diseases Authors: Sumel Ashique Source Type: research
Can Waves of Autoimmune Diseases Occur after The COVID-19 Pandemic?
Infect Disord Drug Targets. 2023 Dec 19. doi: 10.2174/0118715265272448231211101718. Online ahead of print.NO ABSTRACTPMID:38115613 | DOI:10.2174/0118715265272448231211101718 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - December 20, 2023 Category: Infectious Diseases Authors: SeyedAhmad SeyedAlinaghi Pegah Mirzapour Esmaeil Mehraeen Source Type: research
An Unforeseen Spreading of Measles in South Africa
Infect Disord Drug Targets. 2023 Dec 19. doi: 10.2174/0118715265276129231211054120. Online ahead of print.NO ABSTRACTPMID:38115612 | DOI:10.2174/0118715265276129231211054120 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - December 20, 2023 Category: Infectious Diseases Authors: Sumel Ashique Source Type: research
Can Waves of Autoimmune Diseases Occur after The COVID-19 Pandemic?
Infect Disord Drug Targets. 2023 Dec 19. doi: 10.2174/0118715265272448231211101718. Online ahead of print.NO ABSTRACTPMID:38115613 | DOI:10.2174/0118715265272448231211101718 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - December 20, 2023 Category: Infectious Diseases Authors: SeyedAhmad SeyedAlinaghi Pegah Mirzapour Esmaeil Mehraeen Source Type: research
An Unforeseen Spreading of Measles in South Africa
Infect Disord Drug Targets. 2023 Dec 19. doi: 10.2174/0118715265276129231211054120. Online ahead of print.NO ABSTRACTPMID:38115612 | DOI:10.2174/0118715265276129231211054120 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - December 20, 2023 Category: Infectious Diseases Authors: Sumel Ashique Source Type: research
Can Waves of Autoimmune Diseases Occur after The COVID-19 Pandemic?
Infect Disord Drug Targets. 2023 Dec 19. doi: 10.2174/0118715265272448231211101718. Online ahead of print.NO ABSTRACTPMID:38115613 | DOI:10.2174/0118715265272448231211101718 (Source: Infectious Disorders Drug Targets)
Source: Infectious Disorders Drug Targets - December 20, 2023 Category: Infectious Diseases Authors: SeyedAhmad SeyedAlinaghi Pegah Mirzapour Esmaeil Mehraeen Source Type: research
Diagnosis and Management of Latent Tuberculosis Infection: Updates
Infect Disord Drug Targets. 2023 Nov 28. doi: 10.2174/0118715265275319231124053615. Online ahead of print.ABSTRACTIndia has the largest problem of tuberculosis (TB) infection globally (estimated at about 35-40 crores cases), and around 18-36 lakh develop active tuberculosis annually. Latent TB is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens with no evidence of clinically manifested active TB. The progression of a latent infection to active tuberculosis increases several-fold in children < 5 years of age and in people with some or the other form of an immunocompro...
Source: Infectious Disorders Drug Targets - November 30, 2023 Category: Infectious Diseases Authors: Satish Swain Arvind Kumar Vishal Kumar Vishwakarma Adarsh Aayilliath K Ankit Mittal Naveet Wig Source Type: research
Perspective of Secondary Metabolites in Respect of Multidrug Resistance (MDR): A Review
Infect Disord Drug Targets. 2023 Nov 22. doi: 10.2174/0118715265210606231113105225. Online ahead of print.ABSTRACTAberrant and haphazard use of antibiotics has created the development of antimicrobial resistance which is a bizarre challenge for human civilization. This emerging crisis of antibiotic resistance for microbial pathogens is alarming all the nations posing a global threat to human health. It is difficult to treat bacterial infections as they develop resistance to all antimicrobial resistance. Currently used antibacterial agents inhibit a variety of essential metabolic pathways in bacteria, including macro-molecu...
Source: Infectious Disorders Drug Targets - November 30, 2023 Category: Infectious Diseases Authors: Aditi Kaushik Manish Kaushik Gagandeep Kaur Vrinda Gupta Source Type: research
Diagnosis and Management of Latent Tuberculosis Infection: Updates
Infect Disord Drug Targets. 2023 Nov 28. doi: 10.2174/0118715265275319231124053615. Online ahead of print.ABSTRACTIndia has the largest problem of tuberculosis (TB) infection globally (estimated at about 35-40 crores cases), and around 18-36 lakh develop active tuberculosis annually. Latent TB is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens with no evidence of clinically manifested active TB. The progression of a latent infection to active tuberculosis increases several-fold in children < 5 years of age and in people with some or the other form of an immunocompro...
Source: Infectious Disorders Drug Targets - November 30, 2023 Category: Infectious Diseases Authors: Satish Swain Arvind Kumar Vishal Kumar Vishwakarma Adarsh Aayilliath K Ankit Mittal Naveet Wig Source Type: research
Perspective of Secondary Metabolites in Respect of Multidrug Resistance (MDR): A Review
Infect Disord Drug Targets. 2023 Nov 22. doi: 10.2174/0118715265210606231113105225. Online ahead of print.ABSTRACTAberrant and haphazard use of antibiotics has created the development of antimicrobial resistance which is a bizarre challenge for human civilization. This emerging crisis of antibiotic resistance for microbial pathogens is alarming all the nations posing a global threat to human health. It is difficult to treat bacterial infections as they develop resistance to all antimicrobial resistance. Currently used antibacterial agents inhibit a variety of essential metabolic pathways in bacteria, including macro-molecu...
Source: Infectious Disorders Drug Targets - November 30, 2023 Category: Infectious Diseases Authors: Aditi Kaushik Manish Kaushik Gagandeep Kaur Vrinda Gupta Source Type: research
Diagnosis and Management of Latent Tuberculosis Infection: Updates
Infect Disord Drug Targets. 2023 Nov 28. doi: 10.2174/0118715265275319231124053615. Online ahead of print.ABSTRACTIndia has the largest problem of tuberculosis (TB) infection globally (estimated at about 35-40 crores cases), and around 18-36 lakh develop active tuberculosis annually. Latent TB is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens with no evidence of clinically manifested active TB. The progression of a latent infection to active tuberculosis increases several-fold in children < 5 years of age and in people with some or the other form of an immunocompro...
Source: Infectious Disorders Drug Targets - November 30, 2023 Category: Infectious Diseases Authors: Satish Swain Arvind Kumar Vishal Kumar Vishwakarma Adarsh Aayilliath K Ankit Mittal Naveet Wig Source Type: research
Perspective of Secondary Metabolites in Respect of Multidrug Resistance (MDR): A Review
Infect Disord Drug Targets. 2023 Nov 22. doi: 10.2174/0118715265210606231113105225. Online ahead of print.ABSTRACTAberrant and haphazard use of antibiotics has created the development of antimicrobial resistance which is a bizarre challenge for human civilization. This emerging crisis of antibiotic resistance for microbial pathogens is alarming all the nations posing a global threat to human health. It is difficult to treat bacterial infections as they develop resistance to all antimicrobial resistance. Currently used antibacterial agents inhibit a variety of essential metabolic pathways in bacteria, including macro-molecu...
Source: Infectious Disorders Drug Targets - November 30, 2023 Category: Infectious Diseases Authors: Aditi Kaushik Manish Kaushik Gagandeep Kaur Vrinda Gupta Source Type: research
Diagnosis and Management of Latent Tuberculosis Infection: Updates
Infect Disord Drug Targets. 2023 Nov 28. doi: 10.2174/0118715265275319231124053615. Online ahead of print.ABSTRACTIndia has the largest problem of tuberculosis (TB) infection globally (estimated at about 35-40 crores cases), and around 18-36 lakh develop active tuberculosis annually. Latent TB is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens with no evidence of clinically manifested active TB. The progression of a latent infection to active tuberculosis increases several-fold in children < 5 years of age and in people with some or the other form of an immunocompro...
Source: Infectious Disorders Drug Targets - November 30, 2023 Category: Infectious Diseases Authors: Satish Swain Arvind Kumar Vishal Kumar Vishwakarma Adarsh Aayilliath K Ankit Mittal Naveet Wig Source Type: research
Perspective of Secondary Metabolites in Respect of Multidrug Resistance (MDR): A Review
Infect Disord Drug Targets. 2023 Nov 22. doi: 10.2174/0118715265210606231113105225. Online ahead of print.ABSTRACTAberrant and haphazard use of antibiotics has created the development of antimicrobial resistance which is a bizarre challenge for human civilization. This emerging crisis of antibiotic resistance for microbial pathogens is alarming all the nations posing a global threat to human health. It is difficult to treat bacterial infections as they develop resistance to all antimicrobial resistance. Currently used antibacterial agents inhibit a variety of essential metabolic pathways in bacteria, including macro-molecu...
Source: Infectious Disorders Drug Targets - November 30, 2023 Category: Infectious Diseases Authors: Aditi Kaushik Manish Kaushik Gagandeep Kaur Vrinda Gupta Source Type: research
